Cullinan Oncology Inc Live Share Price Today, Share Analysis and Chart

Name: Cullinan Oncology Inc: Is Infosys Ltd. worth buying?
Item: Cullinan Oncology Inc
Rating: 0.98233325
Author: Trendlyne DVM scores

about

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. I...

7.61 0.16 (2.15%)

63.78% Fall from 52W High

6,346

XNAS Volume

XNAS 16 Jul, 2025 9:36 AM (EDT)

Not Eligible

Expensive Valuation

12.8 / 100

Technically Bearish

26.5 / 100

No estimates available

Cullinan Oncology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cullinan Oncology Inc Live Share Price Today, Share Analysis and Chart

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. I...

63.78% Fall from 52W High

SWOT Analysis

Cullinan Oncology Inc Live Price Chart